The Tesla Shock Nobody Sees Coming

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.

Drone Maker Red Cat 'Set To Be Blown Out Of The Sky': Short Seller Claims Management Set 'Almost Impossible' Expectations

Adam Eckert
January 16, 2025

Short-selling investment firm Kerrisdale Capital believes the recent run in shares of Red Cat Holdings Inc (NASDAQ:RCAT) is built on hype rather than reality.

What To Know: Kerrisdale Capital announced a short position against Red Cat on Thursday morning in a report titled, “Flying Blind.” With Red Cat shares having gained more than 1,200% over the past year, the short seller believes Red Cat has reached its peak, at least in the near term.

Kerrisdale attributed most of the run in Red Cat shares to the anticipation of a production award for the U.S. Army’s short-range reconnaissance (SRR) drone.

“But expectations for both the SRR contract size and the potential for follow-on sales bear almost no relationship to reality,” the short seller said.

“Having set almost impossible expectations, Red Cat is set to be blown out of the sky.”

Red Cat is preparing a statement on the Kerrisdale Capital short report, a spokesperson told Benzinga in an email.

Red Cat announced in November that it was selected as the winner of the U.S. Army’s SSR program of record. The company said in the press release that it was “also preparing to meet increased demand across the rest of the U.S. DoD, federal government and allied countries, to support operators and warfighters globally.”

Kerrisdale claimed the contract was preemptively announced without the Army's permission and is “much smaller and less favorable” than Red Cat’s management team has implied.

The short seller said management has talked about the potential for $80 million in revenue in 2025 as a result of the contract, but pointed out the Army’s detailed funding request for 2025 shows that it only expects to spend between $20 and $25 million on drone systems this year.

See Also: Carvana: Bumpy Ride Or Comeback Story? Here’s What The Technicals Suggest

Kerrisdale also claimed Red Cat management has been misleading investors about its manufacturing capacity for years and has pushed the idea that the SSR contract will open up other opportunities within the U.S. defense sector and across NATO militaries, but Kerrisdale believes it’s “nonsense.”

“Red Cat's 2025 guidance excluding the SRR is laughable, and we don't think the company will come close to meeting it,” the short seller said.

Finally, Kerrisdale flagged recent executive departures including the resignation of former CTO George Matus, which occurred about a week after the SSR announcement, as well as the resignation of former CFO Leah Lunger in mid-December.

Both executives sold large blocks of shares upon departure. The short seller also highlighted continued insider selling over the past month from executives including CEO John Thompson.

“Given the slim chances for Red Cat's 2025 plans to come to fruition, shareholders may follow suit,” Kerrisdale said.

Check out Benzinga’s Insider Trades page for Red Cat Holdings and more information. For detailed information on Red Cat Holdings, sign up for Benzinga Pro.

RCAT Price Action: Red Cat shares were down 1.88% at $10.71 at the time of publication Thursday, according to Benzinga Pro.

Read Next:

  • Big Banks Continue To Beat Q4 Earnings As Financial ETF Takes A Breather

Photo: Courtesy of Red Cat Holdings.

Continue Reading...

Popular

Trump keeps saying the GOP mega bill will eliminate taxes on Social Security. It does not

WASHINGTON (AP) — President keeps saying that Republicans' mega legislation will eliminate taxes on federal benefits.

Cathie Wood's Alpha Surge: $250 Million Circle Windfall, Big AMD Buys

Cathie Wood, founder and CEO of ARK Invest, has recently been on a hot streak of successful and high-profile trades through her flagship ARK ETFs. 

The Unlikely Duo Rethinking Wearable Technology - Ad

Why did a surgeon and Snap exec team up? They saw the missing ingredient in the $84T wearables market: behavior. So they built Emteq and invented smart glasses sensors to track real-time expressions, unlocking insights into why we do things. With a $15M term sheet already secured, Emteq is what Big Tech's missing.

Marjorie Taylor Greene: 'Muslim Takeover' Threatens American Women

Rep. Marjorie Taylor Greene (R-Ga.) has expressed her fears regarding what she believes to be the most significant threat to the freedom of American women.

Mystery Seller Behind $105 Million Plot Next to Jeff Bezos Estate Finally Revealed

A plot of land neighboring Jeff Bezos' property in Miami was sold for a staggering $105 million. The undeveloped lot was sold by German investor Mikhail Peleg.

Back This Medical AI Tech - Ad

You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.

BigBear.ai (BBAI) Stock Soars 21%: What's Going On?

Shares of BigBear.ai are trading sharply higher Tuesday afternoon. The rally comes without any new company-specific announcements.

These are the celebs who are attending Jeff Bezos’ Venice wedding

VENICE, Italy (AP) — arrived in Venice on Thursday, leading a star-studded guest list of celebrities descending on the lagoon city for the weekend wedding of Amazon founder Jeff Bezos and Lauren Sánchez.

The Missing Ingredient for Big Tech's $3T Recipe? - Ad

Big Tech doesn't build everything; they buy what's next. And only Emteq's tech offers real behavior insights for smart glasses, key to unlocking the $3T XR market. Their patented sensors track live facial muscle movements. With health-focused smart glasses in demand, only Emteq has this tech.

Lawmakers Investigate Whether Pfizer Delayed COVID-19 Vaccine Results For Political Reasons

House Judiciary subpoenas ex-Pfizer exec Philip Dormitzer amid claims the COVID-19 vaccine announcement was delayed to avoid influencing the 2020 election.

A Historic Gold Announcement Is About to Rock Wall Street - Ad

The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent - and four tiny miners could be your ticket to 100X gains.

Goldman Just Launched Two New Bond ETFs; Here's Why Investors Should Pay Attention

Goldman Sachs Asset Management debuts two new actively managed fixed income ETFs in response to rising demand for active strategies in a volatile rate landscape.

Supreme Court OKs fee that subsidizes phone, internet services in schools, libraries and rural areas

WASHINGTON (AP) — on Friday upheld the fee that is added to phone bills to provide billions of dollars a year in in schools, libraries and rural areas.

Is Elon's Empire Crumbling? - Ad

Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after July 23rd, it may be too late.

Occidental Petroleum, Exxon Mobil, Chevron Surge In Monday Pre-Market: What's Going On?

Occidental Petroleum Corp (NYSE: OXY), Exxon Mobil Corp (NYSE: XOM) and Chevron Corp (NYSE: CVX) climbed 1.95%, 1.53% and 1.31% during Monday pre-market trading session after oil prices have skyrocketed to their highest point since January, sparking concerns about potential supply disruptions.

Wall Street Says BUY GOLD, But... - Ad

While markets wobble, gold keeps smashing records-and banks say it's just beginning. Goldman urges "buy gold" to hedge trade wars; JPMorgan plans $6,000 an ounce and just took delivery of $4 billion in bullion. Yet past bull runs saw 13x-1,000x bigger gains without buying more gold.

Trump's Tariffs, Boeing's Blowout, Tesla's Robotaxi, BYD's European Triumph And GM's Massive Recall: This Week In Mobility

This week's business and finance highlights include Japan's rejection of Trump's auto tariffs, Boeing's scrutiny over a mid-air incident, Tesla's Robotaxi launch, BYD's dominance in Europe, and GM's massive vehicle recall.

T-Mobile Stock (TMUS) Plunges After SoftBank's $4.8B Share Sale: Report

T-Mobile stock is down over 4% after SoftBank reportedly sold $4.8 billion in shares at a discount. This major share sale by a key investor is contributing significantly to the stock's decline Tuesday.

FDA Submission Expected This Summer - Invest Before It Happens - Ad

This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.

Trump's Crypto Ventures, Draper And Cathie Wood's Bitcoin Predictions, MSTR Estimates, And More: This Week In Crypto

The past week in the world of cryptocurrency was nothing short of eventful. From legislative moves aimed at curbing alleged corruption in cryptocurrency ventures to bold predictions about Bitcoin’s dominance, the week was filled with intriguing developments. Here’s a quick recap of the top stories that made headlines.

This Coin Could Surge Like Bitcoin Did Back in 2013... - Ad

A new coin is emerging in the crypto world. And investing in it now could end up like Bitcoin or Ethereum during their first bull runs.

How to Hack a $1.3T Market - Ad

Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.

Here's how millions of people could lose health insurance if Trump's tax bill becomes law

WASHINGTON (AP) — Roughly 11.8 million adults and children will be at risk for losing health insurance if Republicans' domestic policy package becomes a law.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.

This Isn't Your Father's BlackBerry, And Its Comeback Is Gaining Traction

BlackBerry (NYSE: BB) shares rise on better-than-expected Q1 results and raised fiscal guidance. Analysts increase price forecasts.

The Unlikely Duo Rethinking Wearable Technology - Ad

Why did a surgeon and Snap exec team up? They saw the missing ingredient in the $84T wearables market: behavior. So they built Emteq and invented smart glasses sensors to track real-time expressions, unlocking insights into why we do things. With a $15M term sheet already secured, Emteq is what Big Tech's missing.

Back This Medical AI Tech - Ad

You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.

Iran's internet blackout leaves public in dark and creates an uneven picture of the war with Israel

DUBAI, United Arab Emirates (AP) — As hits the one-week mark, Iranians have spent nearly half of the conflict in a near-communication blackout, unable to connect not only with the outside world but also with their neighbors and loved ones across the country.

The Missing Ingredient for Big Tech's $3T Recipe? - Ad

Big Tech doesn't build everything; they buy what's next. And only Emteq's tech offers real behavior insights for smart glasses, key to unlocking the $3T XR market. Their patented sensors track live facial muscle movements. With health-focused smart glasses in demand, only Emteq has this tech.

FDA vaccine official restricted COVID vaccine approvals against the advice of agency staff

WASHINGTON (AP) — The working under Health Secretary recently of two COVID-19 vaccines, disregarding recommendations from government scientists, according to federal documents released Wednesday.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright activatrade.ca
Privacy Policy | Terms of Service